| Literature DB >> 30922080 |
Meike J Saul1,2, Isabell Baumann1,2, Annalisa Bruno3,4, Anne C Emmerich1,2, Julia Wellstein1,2, Sarah M Ottinger2, Annalisa Contursi3,4, Melania Dovizio3,4, Sandra Donnini5, Stefania Tacconelli3,4, Joan Raouf6, Helena Idborg6, Stefan Stein7, Marina Korotkova6, Rajkumar Savai8, Erika Terzuoli5, Gianluca Sala4,9, Werner Seeger8,10, Per-Johan Jakobsson6, Paola Patrignani3,4, Beatrix Suess2, Dieter Steinhilber1.
Abstract
MicroRNAs (miRs) are important posttranscriptional regulators of gene expression. Besides their well-characterized inhibitory effects on mRNA stability and translation, miRs can also activate gene expression. In this study, we identified a novel noncanonical function of miR-574-5p. We found that miR-574-5p acts as an RNA decoy to CUG RNA-binding protein 1 (CUGBP1) and antagonizes its function. MiR-574-5p induces microsomal prostaglandin E synthase-1 (mPGES-1) expression by preventing CUGBP1 binding to its 3'UTR, leading to an enhanced alternative splicing and generation of an mPGES-1 3'UTR isoform, increased mPGES-1 protein expression, PGE2 formation, and tumor growth in vivo. miR-574-5p-induced tumor growth in mice could be completely inhibited with the mPGES-1 inhibitor CIII. Moreover, miR-574-5p is induced by IL-1β and is strongly overexpressed in human nonsmall cell lung cancer where high mPGES-1 expression correlates with a low survival rate. The discovered function of miR-574-5p as a CUGBP1 decoy opens up new therapeutic opportunities. It might serve as a stratification marker to select lung tumor patients who respond to the pharmacological inhibition of PGE2 formation.-Saul, M. J., Baumann, I., Bruno, A., Emmerich, A. C., Wellstein, J., Ottinger, S. M., Contursi, A., Dovizio, M., Donnini, S., Tacconelli, S., Raouf, J., Idborg, H., Stein, S., Korotkova, M., Savai, R., Terzuoli, E., Sala, G., Seeger, W., Jakobsson, P.-J., Patrignani, P., Suess, B., Steinhilber, D. miR-574-5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES-1 induction.Entities:
Keywords: A549 cells; PGE; alternative splicing; lung cancer; prostaglandins
Mesh:
Substances:
Year: 2019 PMID: 30922080 DOI: 10.1096/fj.201802547R
Source DB: PubMed Journal: FASEB J ISSN: 0892-6638 Impact factor: 5.191